PLANTATION, Fla., Dec. 12,
2023 /CNW/ - Akumin Inc. (together with its
subsidiaries, "we", "us", "our," "Akumin" or the "Company") (TSX:
AKU) (OTCPINK: AKUMQ) announced today its financial results for the
quarter ended September 30, 2023 by
filing its Periodic Report on Form 10-Q for the quarterly period
ended September 30, 2023 (the "Form
10-Q") with the U.S. Securities and Exchange Commission on the
Electronic Data Gathering, Analysis, and Retrieval system ("EDGAR")
and with the Canadian Securities Administrators on the System for
Electronic Document Analysis and Retrieval Plus ("SEDAR+"). The
Form 10-Q is available to be viewed by interested parties under the
Company's profile on EDGAR at www.sec.gov/edgar and on SEDAR+ at
www.sedarplus.com.
About Akumin
Akumin is a national outpatient partner of choice for U.S.
hospitals, health systems and physician groups, addressing their
outsourced radiology and oncology needs. Akumin provides fixed-site
outpatient diagnostic imaging services through a network of
approximately 180 owned and/or operated imaging locations, and
outpatient radiology and oncology services and solutions to
approximately 1,000 hospitals and health systems across 47
states. By combining clinical and operational expertise with
the latest advances in technology and informatics, Akumin delivers
unparalleled patient experiences and outcomes. Our radiology
procedures include magnetic resonance imaging (MRI), computed
tomography (CT), positron emission tomography (PET and PET/CT),
ultrasound, diagnostic radiology (X-ray), mammography and other
related procedures; our oncology services include a full suite of
radiation therapy and related offerings. For more information,
visit www.akumin.com and
https://alliancehealthcareservices-us.com.
SOURCE Akumin Inc.